BioSpace News Archive

HUTCHMED Limited announces that results from the confirmatory Phase IIIb clinical trial of savolitinib in patients with mesenchymal epithelial transition factor exon 14 skipping alteration non-small cell lung cancer, were presented during the IASLC 2023 World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer, which took place from September 9 to 12, 2023 in Singapore.

Zura Bio Limited and Benaroya Research Institute announced that they have entered into a sponsored research agreement focused on further characterizing the pivotal role of Interleukin-7 receptor alpha in Thymic Stromal Lymphopoietin and Interleukin-7 signaling pathways.

TISSIUM announced the first clinical use of TISSIUM’s Adhesive Hernia Repair System in patients undergoing laparoscopic ventral hernia repair as part of the ALPHA clinical study taking place in Belgium.

Freudenberg Medical, a global CDMO for finished medical devices, components, and minimally invasive solutions, has amplified its production capacity by introducing an innovative coating process for hypotubes.

Actio Biosciences, a biotechnology company leveraging a novel platform approach to genetics and precision medicine to develop new therapeutics that target shared underlying biology in both rare and common diseases, announced the completion of a $55 million Series A financing.

ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Estradiol Tablets USP.

2seventy bio, Inc. and JW Therapeutics announced their intention to expand their strategic alliance.

HOOKIPA Pharma Inc. announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-statutory options to new employees to purchase an aggregate of 100,000 shares of the Company’s Common Stock under HOOKIPA’s 2023 Inducement Plan.

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the launch of SUREmAb ™, an offering built on the robustness of KBI’s SUREtechnology Platform™, that allows for optimized, safe, and cost-efficient monoclonal antibody (mAb) development and manufacturing.

Perimetrics, Inc., an advanced artificial intelligence (AI) dental diagnostics company, today announced the U.S. Food and Drug Association (FDA) granted clearance for its InnerView® device, including the wireless handpiece, charging base station and disposable tip with embedded smart chips.